Our findings suggest that the activation of platelet PAR1 may be important in the initial stages of tumor metastasis, and early antiplatelet therapy may be of great significance to suppress colorectal cancer metastasis and improve the survival rate. This evidence concerns the gene F2R and colorectal cancer.